Altai Protocol Library

1041 protocols and counting

All protocols with references and links

All protocols reviewed by a Medical Oncologist/Hematologist

All protocols in major guidelines included

Ability to create your own protocols

Kütüphanede Ara Ara

New Reference: Pembrolizumab as adjuvant therapy in completely resected stage IIB or IIC melanoma 

New Reference: Pembrolizumab as adjuvant therapy in completely resected stage IIB or IIC melanoma 
Study:
  • Double-blind, randomised, phase 3 study (KEYNOTE-716)
  • Newly diagnosed, completely resected stage IIB or IIC melanoma
  • Pembrolizumab (n=483) or placebo (n=486)
Efficacy:
  • RFS @ 20.9 mos: 85% vs. 76% [ HR: 0.61 (0·45–0·82)]
  • mRFS not reached
Safety:
  • Grade >= 3 AEs: 16% vs 4%
  • AEs related death: 0 vs 4 patients

Lancet. 2022 Apr 30;399(10336):1718-1729.

Luke, Jason J et al. “Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial

https://doi.org/10.1016/s0140-6736(22)00562-1

Reviewed by Hasan Çağrı Yıldırım, MD on May 30, 2022

Altai Chemo Planner

Quickly Prepare Accurate Chemotherapy Orders

Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.

Learn More